期刊文献+

土贝母苷甲通过调控糖代谢重编程抑制肝癌细胞增殖

TBMS I inhibits the proliferation of liver cancer cells by regulating sugar metabolism reprogramming
在线阅读 下载PDF
导出
摘要 目的探讨土贝母苷甲(TBMS I)对肝癌细胞增殖的影响及其分子机制。方法采用MTS实验和克隆形成实验检测不同浓度TBMS I对肝癌细胞株MHCC97-H生长的影响。采用检测葡萄糖摄取、乳酸生成、乳酸脱氢酶(LDH)活性、细胞外液pH、细胞氧耗和线粒体呼吸链复合体Ⅳ活性的实验,分析TBMS I对肝癌细胞糖酵解、氧化磷酸化的影响。采用qRT-PCR和Western blot实验检测肝癌细胞株MHCC97-H中缺氧诱导因子-1α(HIF-1α)的表达。结果TBMS I作用使肝癌细胞的增殖能力下降,且呈一定的剂量和时间依赖效应;使葡萄糖摄取和乳酸生成减少,LDH活性降低,细胞外培养液pH升高,细胞氧耗和线粒体呼吸链复合体Ⅳ活性增加。结论TBMS I通过抑制HIF-1α的表达抑制细胞糖酵解和促进氧化磷酸化,进而抑制肝癌细胞增殖。 Objective This study aims to investigate the impact of Tubeimoside I on the proliferation of liver cancer cells and its molecular mechanism.Methods MTS assay and colony formation assay were conducted to examine the effects of different concentrations of Tubeimoside I on the growth of MHCC97-H liver cancer cells.Glucose uptake,lactate production,LDH activity,extracellular pH,cellular oxygen consumption and mitochondrial respiratory chain complex IV activity were measured to analyze the influence of Tubeimoside I on glycolysis and oxidative phosphorylation in liver cancer cells.qRT-PCR and Western blot were performed to detect the expression of HIF1αin MHCC97-H liver cancer cells.Results Tubeimoside I treatment decreased the proliferation ability of liver cancer cells in a dose-and time-dependent manner.It also reduced glucose uptake,lactate production and LDH activity,increased extracellular pH,and enhanced cellular oxygen consumption and mitochondrial respiratory chain complex IV activity.Conclusion Tubeimoside I inhibits cell glycolysis and promotes oxidative phosphorylation by suppressing the expression of HIF-1α,thereby suppressing the proliferation of liver cancer cells.
作者 鲁睿 董佳琪 张乐 田凯乐 路蔓 LU Rui;DONG Jiaqi;ZHANG Le;TIAN Kaile;LU Man(Department of Interventional Pain Medicine,Tangdu Hospital,Air Force Medical University,Xi'an 710038,China;Shanxi University of Chinese Medicine,Xianyang 710046,Shanxi,China;Department of Laboratory Medicine,Tangdu Hospital,Air Force Medical University,Xi'an 710038,China)
出处 《西部医学》 2024年第11期1594-1599,共6页 Medical Journal of West China
基金 陕西省自然科学基础研究计划项目一般项目(面上)(2024JC-YBMS-731)。
关键词 肝细胞肝癌 土贝母苷甲 HIF-1Α 增殖 糖代谢重编程 Hepatocellular carcinoma Tubeimoside I(TBMS I) HIF-1α Proliferation Reprogramming of glucose metabolism
作者简介 通讯作者:路蔓,E-mail:luman0226@163.com。
  • 相关文献

参考文献5

二级参考文献31

  • 1Ru-xianLIN,Chao-weiTUO,Qiu-junLUE,WeiZHANG,Sheng-qiWANG.Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model[J].Acta Pharmacologica Sinica,2005,26(6):762-768. 被引量:14
  • 2Llovet Josep M,Ricci Sergio,Mazzaferro Vincenzo,Hilgard Philip,Gane Edward,Blanc Jean-Frédéric,de Oliveira Andre Cosme,Santoro Armando,Raoul Jean-Luc,Forner Alejandro,Schwartz Myron,Porta Camillo,Zeuzem Stefan,Bolondi Luigi,Greten Tim F,G.Sorafenib in advanced hepatocellular carcinoma. The New England Quarterly . 2008
  • 3R.CABRERA,D. R.NELSON.Review article: the management of hepatocellular carcinoma[J]. Alimentary Pharmacology & Therapeutics . 2010 (4)
  • 4Dongjun Luo,Zhongxia Wang,Junyi Wu,Chunping Jiang,Junhua Wu,Jingmin Zhao.The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma[J]. BioMed Research International . 2014
  • 5Yiting Cao,Joseph M. Eble,Ejung Moon,Hong Yuan,Douglas H. Weitzel,Chelsea D. Landon,Charleen Yu-Chih Nien,Gabi Hanna,Jeremy N. Rich,James M. Provenzale,Mark W. Dewhirst.Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin[J]. Cancer Research . 2013 (20)
  • 6Zongquan Xu,Enyu Liu,Cheng Peng,Yunguang Li,Zhaobin He,Chuanzong Zhao,Jun Niu.Role of hypoxia-inducible-1α in hepatocellular carcinoma cells usinga Tet-on inducible system to regulate its expression in vitro[J]. Oncology Reports . 2012 (2)
  • 7Jamie Y. Ding,Christian W. Kreipke,Patrick Schafer,Steven Schafer,Susan L. Speirs,José A. Rafols.Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1α expression[J]. Brain Research . 2009
  • 8Xiong‐ZhiWu,Guang‐RuXie,DanChen.Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma[J]. Journal of Gastroenterology and Hepatology . 2007 (8)
  • 9Geum-Youn Gwak,Jung-Hwan Yoon,Kang Mo Kim,Hyo-Suk Lee,Jin Wook Chung,Gregory J. Gores.Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression[J]. Journal of Hepatology . 2004 (3)
  • 10Chi V Dang,Gregg L Semenza.Oncogenic alterations of metabolism[J]. Trends in Biochemical Sciences . 1999 (2)

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部